Sector Gamma AS’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,240
| Closed | -$3.7M | – | 31 |
|
|
2024
Q2 | $3.7M | Sell |
15,240
-12,343
| -45% | -$3M | 1.38% | 24 |
|
|
2024
Q1 | $4.12M | Sell |
27,583
-4,509
| -14% | -$674K | 1.16% | 25 |
|
|
2023
Q4 | $6.14M | Sell |
32,092
-20,876
| -39% | -$4M | 1.49% | 23 |
|
|
2023
Q3 | $9.38M | Buy |
52,968
+24,901
| +89% | +$4.41M | 2.4% | 17 |
|
|
2023
Q2 | $5.33M | Buy |
28,067
+678
| +2% | +$129K | 1.19% | 23 |
|
|
2023
Q1 | $5.49M | Buy |
+27,389
| New | +$5.49M | 1.33% | 24 |
|
|
2022
Q4 | – | Sell |
-6,921
| Closed | -$1.39M | – | 32 |
|
|
2022
Q3 | $1.39M | Sell |
6,921
-35,923
| -84% | -$7.19M | 0.36% | 29 |
|
|
2022
Q2 | $6.25M | Sell |
42,844
-16,407
| -28% | -$2.39M | 1.4% | 21 |
|
|
2022
Q1 | $9.68M | Buy |
+59,251
| New | +$9.68M | 2.1% | 17 |
|
|
2021
Q3 | – | Sell |
-58,017
| Closed | -$9.84M | – | 30 |
|
|
2021
Q2 | $9.84M | Sell |
58,017
-1,772
| -3% | -$300K | 1.74% | 24 |
|
|
2021
Q1 | $8.44M | Buy |
59,789
+30,174
| +102% | +$4.26M | 1.55% | 23 |
|
|
2020
Q4 | $3.85M | Buy |
29,615
+10,124
| +52% | +$1.32M | 0.73% | 28 |
|
|
2020
Q3 | $2.84M | Sell |
19,491
-22,193
| -53% | -$3.23M | 0.65% | 26 |
|
|
2020
Q2 | $6.17M | Sell |
41,684
-12,700
| -23% | -$1.88M | 1.27% | 25 |
|
|
2020
Q1 | $5.92M | Buy |
+54,384
| New | +$5.92M | 1.26% | 27 |
|
|
2019
Q4 | – | Sell |
-96,900
| Closed | -$7.79M | – | 38 |
|
|
2019
Q3 | $7.79M | Buy |
96,900
+25,000
| +35% | +$2.01M | 1.32% | 28 |
|
|
2019
Q2 | $5.22M | Buy |
+71,900
| New | +$5.22M | 0.84% | 31 |
|
|
2019
Q1 | – | Sell |
-59,437
| Closed | -$4.33M | – | 34 |
|
|
2018
Q4 | $4.33M | Buy |
59,437
+14,000
| +31% | +$1.02M | 0.73% | 30 |
|
|
2018
Q3 | $3.98M | Buy |
45,437
+12,937
| +40% | +$1.13M | 0.62% | 27 |
|
|
2018
Q2 | $3.2M | Buy |
+32,500
| New | +$3.2M | 0.53% | 27 |
|
|
2018
Q1 | – | Sell |
-9,400
| Closed | -$1.19M | – | 31 |
|
|
2017
Q4 | $1.19M | Buy |
+9,400
| New | +$1.19M | 0.2% | 36 |
|